Table of Content

1 Industry Outlook
1.1 Industry Overview
1.1.1 Global Driver for Pharmaceutical Demand
1.1.2 Pharmaceutical Spending Region Wise
1.1.3 R&D Pipeline in Pharmaceutical Industry
1.1.4 Top Pharma Drugs by Sales in 2017 ($Million)
1.2 Total Addressable Market
2 Report Outline
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 Market Snapshot
3.1 Market Definition – Infoholic Research 3.2 Segmented Addressable Market (SAM)
3.3 Industry Trends
3.4 Related Markets
3.4.1 Parkinson’s Disease
4 Market Outlook
4.1 Market Segmentation
4.2 Porter 5 (Five) Forces
5 Market Characteristics
5.1 Market Dynamics
5.1.1 Drivers
5.1.1.1 Promising pipeline in development
5.1.1.2 Increase in geriatric population
5.1.2 Restraints
5.1.2.1 Failures of late-stage drugs
5.1.2.2 Restricted awareness about Alzheimer’s disease
5.1.3 Opportunities
5.1.3.1 Emerging novel diagnostic technologies
5.1.3.2 Investment in biomarkers for drug development
5.1.4 DRO – Impact Analysis
5.2 Key Stakeholders
6 Molecule Type: Market Size and Analysis
6.1 Overview
6.2 Cholinesterase Inhibitors
6.3 NMDA Receptor Antagonists
6.4 Others
7 Distribution Channel: Market Size and Analysis
7.1 Overview
7.2 Hospital Pharmacies
7.3 Retail Pharmacies
7.4 E Pharmacies
8 Regions: Market Size and Analysis
8.1 Overview
8.2 North America
8.3 Europe
8.4 Asia Pacific
8.5 Rest of the World
9 Competitive Landscape
10 Vendors Profile
10.1 Novartis AG
10.2 Eisai Co. Ltd.
10.3 Pfizer Inc.
10.4 Eli Lilly & Company
10.5 Johnson & Johnson
11 Companies to Watch for
11.1 Daiichi Sankyo Company Ltd
11.2 F. Hoffmann-La Roche
11.3 H. Lundbeck A/S
11.4 TauRx Therapeutics Ltd
11.5 Allergan
Annexure
? Abbreviations

?



List of Figures


Charts

CHART 1 GLOBAL PHARMACEUTICAL R&D SPENDING (2010–2016)
CHART 2 ESTIMATED R&D INVESTMENT BY TOP 10 COMPANIES ($BN)
CHART 3 RESEARCH METHODOLOGY OF GLOBAL ALZHEIMER’S THERAPEUTICS MARKET
CHART 4 GLOBAL ALZHEIMER’S THERAPEUTICS MARKET REVENUE, 2018–2025 ($MILLION)
CHART 5 GLOBAL ALZHEIMER’S THERAPEUTICS MARKET SEGMENTATION
CHART 6 PORTERS 5 FORCES ON GLOBAL ALZHEIMER’S THERAPEUTICS MARKET
CHART 7 PEST ANALYSIS OF GLOBAL ALZHEIMER’S THERAPEUTICS MARKET
CHART 8 MARKET DYNAMICS – DRIVERS, RESTRAINTS & OPPORTUNITIES
CHART 9 DRO - IMPACT ANALYSIS OF GLOBAL ALZHEIMER’S THERAPEUTICS MARKET
CHART 10 KEY STAKEHOLDERS OF GLOBAL ALZHEIMER’S THERAPEUTICS MARKET
CHART 11 GLOBAL ALZHEIMER’S THERAPEUTICS MARKET REVENUE, BY PRODUCT, 2018 ($MILLION)
CHART 12 CHOLINESTERASE INHIBITORS MARKET REVENUE, 2018–2025 ($MILLION)
CHART 13 NMDA RECEPTOR ANTAGONISTS MARKET REVENUE, 2018–2025 ($MILLION)
CHART 14 OTHERS MARKET REVENUE, 2018–2025 ($MILLION)
CHART 15 GLOBAL ALZHEIMER’S THERAPEUTICS MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2018–2025 ($MILLION)
CHART 16 HOSPITAL PHARMACIES MARKET REVENUE, 2018–2025 ($MILLION)
CHART 17 RETAIL PHARMACIES MARKET REVENUE, 2018–2025 ($MILLION)
CHART 18 E PHARMACIES MARKET REVENUE, 2018–2025 ($MILLION)
CHART 19 GLOBAL ALZHEIMER’S THERAPEUTICS MARKET BY REGIONAL SEGMENTATION, 2018 (%)
CHART 20 GLOBAL ALZHEIMER’S THERAPEUTICS MARKET BY REGIONAL SEGMENTATION, 2025 (%)
CHART 21 ALZHEIMER’S THERAPEUTICS MARKET REVENUE IN NORTH AMERICA, 2018–2025 ($MILLION)
CHART 22 ALZHEIMER’S THERAPEUTICS MARKET REVENUE IN EUROPE, 2018–2025 ($MILLION)
CHART 23 ALZHEIMER’S THERAPEUTICS MARKET REVENUE IN ASIA PACIFIC, 2018–2025 ($MILLION)
CHART 24 ALZHEIMER’S THERAPEUTICS MARKET REVENUE IN REST OF THE WORLD, 2018–2025 ($MILLION)

?

 

List of Tables


?
Tables

TABLE 1 ALZHEIMER’S THERAPEUTICS MARKET REVENUE, BY PRODUCT, 2018–2025 ($MILLION)
TABLE 2 ALZHEIMER’S THERAPEUTICS MARKET REVENUE, BY TYPE, 2018–2025 ($MILLION)
TABLE 3 ALZHEIMER’S THERAPEUTICS MARKET REVENUE, BY GEOGRAPHY, 2018–2025 ($MILLION)
TABLE 4 BUSINESS SUMMARY: NOVARTIS AG
TABLE 5 BUSINESS SUMMARY: EISAI CO. LTD
TABLE 6 BUSINESS SUMMARY: PFIZER INC
TABLE 7 BUSINESS SUMMARY: ELI LILLY & COMPANY
TABLE 8 BUSINESS SUMMARY: JOHNSON & JOHNSON
TABLE 9 BUSINESS SUMMARY: DAIICHI SANKYO COMPANY LTD
TABLE 10 BUSINESS SUMMARY: F. HOFFMANN-LA ROCHE
TABLE 11 BUSINESS SUMMARY: H. LUNDBECK A/S
TABLE 12 BUSINESS SUMMARY: TAURX THERAPEUTICS LTD

?